Abstract
Human embryonic stem cells are pluripotent cells typically derived from blastulating embryos that have become excess to clinical needs in assisted reproduction programs. They provide cellular models for embryonic development and disease, and are thought to be useful for future cell replacement therapies and regenerative medicine. Here we describe methods to derive human embryonic stem cell lines. This includes blastocyst cryopreservation using a highly efficient vitrification protocol, the production and use of fibroblast feeder cells, embryo plating and passaging of resulting cellular outgrowths, and cryopreservation of putative stem cells lines.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Thomson JA, Itskovitz-Eldor J, Shapiro SS et al (1998) Embryonic stem cell lines derived from human blastocysts. Science 282:1145–1147
Pouton CW, Haynes JM (2007) Embryonic stem cells as a source of models for drug discovery. Nat Rev Drug Discov 6:605–616
Chong JJ, Yang X, Don CW et al (2014) Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature. doi:10.1038/nature13233
Roy TK, Bradley CK, Bowman MC et al (2014) Single-embryo transfer of vitrified-warmed blastocysts yields equivalent live-birth rates and improved neonatal outcomes compared with fresh transfers. Fertil Steril 101:1294–1301
Peura TT, Schaft J, Stojanov T (2010) Derivation of human embryonic stem cell lines from vitrified human embryos. Methods Mol Biol 584:21–54
Thomson JA, Kalishman J, Golos TG et al (1995) Isolation of a primate embryonic stem cell line. Proc Natl Acad Sci U S A 92:7844–7848
Crook JM, Peura TT, Kravets L et al (2007) The generation of six clinical-grade human embryonic stem cell lines. Cell Stem Cell 1:490–494
Peura T, Bosman A, Chami O et al (2008) Karyotypically normal and abnormal human embryonic stem cell lines derived from PGD-analyzed embryos. Cloning Stem Cells 10:203–216
Bradley CK, Scott HA, Chami O et al (2011) Derivation of Huntington’s disease-affected human embryonic stem cell lines. Stem Cells Dev 20:495–502
Bradley CK, Peura T, Dumevska B et al (2014) Cell lines from morphologically abnormal discarded IVF embryos are typically euploid and unaccompanied by intrachromosomal aberrations. Reprod Biomed Online 28:780–788
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Bradley, C.K., Schaft, J., Roy, T.K., Dumevska, B., Peura, T.T. (2014). Derivation of Human Embryonic Stem Cell Lines from Vitrified Human Blastocysts. In: Turksen, K. (eds) Human Embryonic Stem Cell Protocols. Methods in Molecular Biology, vol 1307. Humana Press, New York, NY. https://doi.org/10.1007/7651_2014_85
Download citation
DOI: https://doi.org/10.1007/7651_2014_85
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2667-1
Online ISBN: 978-1-4939-2668-8
eBook Packages: Springer Protocols